Browse
related articles
3rd Pfizer Ophthamology Forum
- United Arab Emirates: Sunday, April 09 - 2006 at 14:55
More than 300 doctors from across Africa and the Middle East will gather in Dubai from April 12 to discuss the latest international trends in the treatment of various eye diseases and conditions. The scientific meeting, held under the patronage of the Dubai Department of Health and sponsored by Pfizer Corporation, will provide participating doctors with an opportunity to learn more about advances in treatment from US, European, and Australian physicians.
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
- » Nokia N900 to hit UAE stores
- » Burj Dubai enters final leg of construction
- » Boeing to showcase tailored portfolio of products and services at Dubai Air Show 2009
- » Abu Dhabi residential city nears completion
- » Marriott International announces the signing of five hotels for its newly established Middle East and Africa region
Peter J. CooperSunday, April 09 - 2006 at 14:55 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
This article was updated on Wed Nov 22 2006.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
It looks like you are using a Mac - check out our 
Web Feeds